FASN and prostate cancer: Preliminary results from the Uppsala Longitudinal Study of Adult Men (ULSAM) cohort showed that men with higher levels of fatty acid synthase (FASN) had an increased risk of prostate cancer death compared to patients with normal levels (unpublished data).